BRISTOL-MYERS SQUIBB AND OTSUKA PHARMACEUTICAL COMPANY LAUNCH NEW RAPIDLY DISINTEGRATING ORAL ANTIPSYCHOTIC MEDICATION ABILIFY DISCMELT (ARIPIPRAZOLE)

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced the launch of ABILIFY DISCMELT (aripiprazole) Orally Disintegrating Tablets, a new oral form of the antipsychotic medication ABILIFY (aripiprazole) that disintegrates rapidly in the mouth. The U.S. Food and Drug Administration approved ABILIFY DISCMELT on June 7, 2006.

Bristol-Myers Squibb (http://www.bms.com/news/press/data/fg_press_release_6688.html)